A genetic strategy for combined screening and localized imaging of breast cancer
- PMID: 20658194
- PMCID: PMC4359509
- DOI: 10.1007/s11307-010-0377-y
A genetic strategy for combined screening and localized imaging of breast cancer
Abstract
Purpose: Improvements are needed for the early detection of breast cancer, as current imaging methods lack sensitivity to detect small tumors and assess their disease phenotype.
Procedures: To address this issue, the dual reporter adenoviral vector (Ad5/3-Id1-SEAP-Id1-mCherry) was produced with a cancer-specific Id1 promoter driving expression of a blood-based screening reporter (secreted embryonic alkaline phosphatase, SEAP) and a fluorescent imaging reporter (mCherry). This diagnostic system was assessed for its screening potential on breast cancer cell lines of various aggressive phenotypes. Reporter expression was measured and correlated with promoter level expression using Western blot. Adenovirus receptor expression was normalized against reporter expression with luciferase infectivity assays. Ad5/3-Id1-SEAP-Id1-mCherry infected MDA-MB-231 cells combined with uninfected cells were implanted into the mammary fat pad of athymic nude mice to recapitulate low-dose tumor delivery. Id1 driven SEAP expression and mCherry imaging were monitored to validate diagnostic sensitivity and efficacy.
Results: Infected breast cancer cell lines displayed SEAP levels in the media that were 10-fold above background by 2 days after infection. Ad5/3-Id1-SEAP-Id1-mCherry infected cells (multiplicity of infection = 10) implanted in athymic nude mice demonstrated a 14-fold increase in serum SEAP levels over baseline when as little as 2.5% of the tumor contained infected cells. This robust response was also found for the mCherry reporter, which was clearly visible in tumor xenografts on day 2 post implantation.
Conclusions: This diagnostic system that combines screening with imaging for early detection and monitoring of breast cancer can be easily extended to other reporters/modalities and cancer-targeting methods. Combining screening with imaging in a genetic, cancer-specific mechanism allows sensitive multi-modal detection and localization of breast cancer.
Figures




Similar articles
-
A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging.Gene Ther. 2014 Oct;21(10):897-902. doi: 10.1038/gt.2014.68. Epub 2014 Jul 24. Gene Ther. 2014. PMID: 25056609 Free PMC article.
-
Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.Cancer Gene Ther. 2012 Aug;19(8):545-52. doi: 10.1038/cgt.2012.29. Epub 2012 Jun 1. Cancer Gene Ther. 2012. PMID: 22653385 Free PMC article.
-
Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts.Technol Cancer Res Treat. 2003 Apr;2(2):171-80. doi: 10.1177/153303460300200214. Technol Cancer Res Treat. 2003. PMID: 12680799
-
[Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].Nan Fang Yi Ke Da Xue Xue Bao. 2011 Nov;31(11):1812-8. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 22126756 Chinese.
-
Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug efficacy in ovarian cancer xenografts.Gynecol Oncol. 2000 Sep;78(3 Pt 1):373-9. doi: 10.1006/gyno.2000.5925. Gynecol Oncol. 2000. PMID: 10985897
Cited by
-
A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging.Gene Ther. 2014 Oct;21(10):897-902. doi: 10.1038/gt.2014.68. Epub 2014 Jul 24. Gene Ther. 2014. PMID: 25056609 Free PMC article.
-
Synthetic biomarkers: a twenty-first century path to early cancer detection.Nat Rev Cancer. 2021 Oct;21(10):655-668. doi: 10.1038/s41568-021-00389-3. Epub 2021 Sep 6. Nat Rev Cancer. 2021. PMID: 34489588 Free PMC article. Review.
-
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.Cancer Sci. 2022 Jun;113(6):1919-1929. doi: 10.1111/cas.15369. Epub 2022 Apr 18. Cancer Sci. 2022. PMID: 35398956 Free PMC article. Review.
-
Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.Cancer Gene Ther. 2012 Aug;19(8):545-52. doi: 10.1038/cgt.2012.29. Epub 2012 Jun 1. Cancer Gene Ther. 2012. PMID: 22653385 Free PMC article.
-
Cancer imaging: Gene transcription-based imaging and therapeutic systems.Int J Biochem Cell Biol. 2012 May;44(5):684-9. doi: 10.1016/j.biocel.2012.02.001. Epub 2012 Feb 10. Int J Biochem Cell Biol. 2012. PMID: 22349219 Free PMC article. Review.
References
-
- Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41. - PubMed
-
- Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94:1445–1457. - PubMed
-
- Baines CJ, Miller AB, Bassett AA. Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer. 1989;63:1816–1822. - PubMed
-
- Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–518. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous